About Project IMP-ACT
Investigational Medicinal Products: Awareness, Compliance & Training
The initiative focuses on strengthening awareness, compliance and practical capability in the governance, preparation, modification, packaging, labelling and supply of Investigational Medicinal Products (IMPs) for Australian clinical trials.
The four components are:
📊 National Benchmark Survey — identify current practices, challenges and capability gaps.
🤝 Executive Roundtable — bring stakeholders together to discuss findings and practical solutions.
🎓 Free Educational Webinar — share practical guidance, insights and recommendations with the wider clinical research community.
📄 Industry White Paper — consolidate findings and develop a risk assessment tool for the sector.
Together, these activities aim to strengthen sector awareness, support compliant practices and build capability across Australian clinical research.